Latus Bio secures $54m for CNS gene therapy development
Latus Bio, a biotechnology company specialising in new gene therapy candidates for central nervous system (CNS) disorders, has announced its launch alongside an initial $54m Series A financing.
Beverly Davidson News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Beverly Davidson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Beverly Davidson Today - Breaking & Trending Today
Latus Bio Raises $54M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Hereditary Disease Foundation Announces Recipients of
Each Team Receives $1 Million for Research to Develop Treatments for Huntington’s Disease...
Source: globenewswire.com
West Seattle Blog… | Remembering Martin S. Davidson, 1967-2023
West Seattle news, 24/7
Source: westseattleblog.com
Siren Biotechnology Launches to Pioneer Universal AAV
Novel approach combines the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single...
Source: globenewswire.com